Beruflich Dokumente
Kultur Dokumente
Background: Functional imaging studies of major Results: A full course of CBT resulted in significant clini-
depressive disorder demonstrate response-specific cal improvement in the 14 study completers (mean±SD
regional changes following various modes of antide- posttreatment Hamilton Depression Rating Scale score
pressant treatment. of 6.7±4). Treatment response was associated with sig-
nificant metabolic changes: increases in hippocampus and
dorsal cingulate (Brodmann area [BA] 24) and de-
Objective: To examine changes associated with cogni-
creases in dorsal (BA 9/46), ventral (BA 47/11), and me-
tive behavior therapy (CBT).
dial (BA 9/10/11) frontal cortex. This pattern is distinct
from that seen with paroxetine-facilitated clinical recov-
Methods: Brain changes underlying response to CBT ery where prefrontal increases and hippocampal and sub-
were examined using resting-state fluorine-18–labeled de- genual cingulate decreases were seen.
oxyglucose positron emission tomography. Seventeen un-
medicated, unipolar depressed outpatients (mean±SD age, Conclusions: Like other antidepressant treatments, CBT
41±9 years; mean ± SD initial 17-item Hamilton Depres- seems to affect clinical recovery by modulating the func-
sion Rating Scale score, 20 ± 3) were scanned before and tioning of specific sites in limbic and cortical regions. Unique
after a 15- to 20-session course of outpatient CBT. Whole- directional changes in frontal cortex, cingulate, and hip-
brain, voxel-based methods were used to assess response- pocampus with CBT relative to paroxetine may reflect mo-
specific CBT effects. A post hoc comparison to an inde- dality-specific effects with implications for understanding
pendent group of 13 paroxetine-treated responders was mechanisms underlying different treatment strategies.
also performed to interpret the specificity of identified
CBT effects. Arch Gen Psychiatry. 2004;61:34-41
R
ANDOMIZED CLINICAL TRIALS lular signaling effects. Requisite brain re-
in patients with both mild gions that mediate these events are
and severe major depres- unknown, although putative primary sites
sion consistently demon- of action in the dorsal raphe, locus ce-
strate similar rates of re- ruleus, hippocampus, and hypothalamus
sponse to cognitive behavior therapy (CBT) are well described, with documented sec-
and antidepressant pharmacotherapy.1,2 Al- ondary changes in frontal cortex also re-
though it is generally assumed that these ported.11-16 Neuroimaging studies17 of medi-
disparate treatments have different pri- cation effects show a similar time course
mary targets of action, with cortical “top- of differential acute and chronic subcorti-
down” vs subcortical or “bottom-up” cal and cortical changes. Across stud-
mechanisms theorized,3-5 definitive neu- ies17-21 of antidepressant response, frontal
ral mechanisms that mediate antidepres- cortex changes are the most consistently
sant response are not yet characterized for reported, with normalization of frontal
From the Rotman Research either treatment modality. overactivity and underactivity described.
Institute at Baycrest Centre Preclinical studies6-10 of antidepres- Additionally, changes have been seen in
(Ms Goldapple and sant medications emphasize a bottom-up limbic and subcortical regions, including
Dr Mayberg) and Department
chain of events, including aminergic reup- the subgenual cingulate, hippocampus,
of Psychiatry, Centre for
Addiction and Mental Health take inhibition and associated presynaptic posterior cingulate, and insula, with de-
(Drs Segal, Lau, Bieling, autoregulatory desensitization, up- and creased activity the most commonly ob-
Kennedy, and Mayberg and down-regulation of multiple postsynaptic served effect.17,19-23
Ms Garson), University of receptor sites, and receptor-mediated sec- In contrast, little is known about brain
Toronto, Toronto, Ontario. ond messenger and neurotrophic intracel- mechanisms that mediate clinical re-
TREATMENT PROTOCOL Statistical analyses were performed using SPM99 statistical soft-
ware (Wellcome Department of Cognitive Neurology, Lon-
All patients received 15 to 20 individualized outpatient ses- don, England) implemented in Matlab (version 5.3; Math-
sions of CBT. Treatment was conducted by 1 of 2 trained CBT works Inc, Sherborn, Mass). The data were first screened for
Abbreviations: BA, Brodmann area; CBT, cognitive behavior therapy; ↓ decrease; ↑, increase.
*Coordinates in millimeters relative to anterior commissure. x Indicates right (+)/left (−); y, anterior (+)/posterior (−); and z, superior (+)/inferior (−).
†z Scores greater than 2.6 correspond to P⬍.01; z scores greater than 3.09 correspond to P⬍.001 (2-tailed).
‡Significant in conjunction analysis: CBT changes vs paroxetine changes, P⬍.005.
distributional properties, outliers, and missing values. This pro- tically contrasted to those seen in a previously published data
cess rejected no scans. All scans were then normalized to the set of comparably recruited depressed men (n=13; mean±SD
Montreal Neurological Institute’s ICBM 152 stereotactic tem- age, 36±10 years; mean±SD education, 15±2 years; 7 unmar-
plate within SPM99, which references brain locations in 3-di- ried; mean ± SD HDRS score, 22.4 ± 3.6) who had been simi-
mensional space relative to the anterior commissure.45,46 The larly scanned following clinical response to 6 weeks of parox-
images were then corrected for differences in the whole-brain etine treatment.21 A conjunctional analysis using statistical
global mean and smoothed using a gaussian kernel to a final criteria identical to those described herein was performed to
in-plane resolution of 10 mm at full width at half maximum. directly compare the change pattern of CBT responders to that
Absolute glucose metabolic rates were not calculated. of paroxetine responders ([CBT scan 2-1] −[paroxetine scan
Response-specific CBT effects were the primary focus of 2-1]). The specific paroxetine change pattern was also exam-
this study, reflected by the following series of statistical analy- ined separately to determine if significant differences in the con-
ses. Significant regional changes before and after treatment were junctional analysis were due to differences in magnitude of the
first assessed using SPM and a pairwise random-effects de- same change or distinct treatment-specific effects of each in-
sign.47,48 Based on previous results of antidepressant medica- tervention. Scans from the paroxetine treatment group were ac-
tion effects,17 peak voxel value significance thresholds were set quired with the same PET camera and an identical scanning
at P⬍.01 (uncorrected) for 5 targeted regions (ventral sub- protocol to that used for the CBT study. Furthermore, the par-
genual cingulate Brodmann area [BA] 25, dorsal anterior cin- oxetine raw data were reprocessed and reanalyzed in SPM99
gulate BA 24, dorsolateral prefrontal cortex BA 9/46, hippo- to match all variables used for the primary CBT analyses. In
campus, and posterior cingulate BA 23/31) and at P⬍.001 the absence of a controlled randomized trial of CBT and medi-
(uncorrected) for all other regions. Cluster significance thresh- cation, this set of post hoc analyses provided a critical perspec-
olds were set at 50 contiguous voxels (voxel=8 mm3) to fur- tive toward interpreting the main CBT response findings. Base-
ther reduce type I errors introduced by potential noise. Result- line scans for the 2 groups were also compared.
ing t values were converted to z scores, with brain locations
reported as x, y, and z coordinates in Montreal Neurological
Institute space with approximate BAs identified by mathemati- RESULTS
cal transformation of SPM99 coordinates into Talairach space49
(additional information available at http://www.mrc-cbu.cam CLINICAL EFFECTS
.ac.uk/Imaging/) (Table).
To assist in interpreting any identified metabolic changes Fourteen of the 17 patients completed the full treat-
with CBT, several additional post hoc analyses were per- ment course (mean±SD number of sessions, 17.7±2 for
formed. Metabolic changes with response to CBT were statis- 26±7 weeks). Three participants withdrew within the first
Treatment with CBT was associated with significant re- +32 +36 +40
POST HOC ANALYSES wise were due to unique paroxetine treatment effects
(Table). Similar for the 2 treatments were decreases in
The conjunctional analysis contrasting CBT response ventral prefrontal cortex (BA 47).
change to paroxetine response change identified signifi- Direct comparison of baseline scans for the CBT and
cant differences between the 2 treatments in numerous paroxetine groups demonstrated no significant differ-
cortical and limbic regions (Table): dorsolateral prefron- ences. There were also no significant correlations be-
tal (BA 9), ventromedial frontal (BA 10/11), and infe- tween metabolism and weeks of treatment across groups.
rior parietal (BA 40) cortices, as well as insula, hippo- Finally, covarying the pretreatment and posttreatment
campus, ventral subgenual cingulate (BA 25), anterior changes with the HDRS score nullified the changes in both
and dorsal midcingulate (BA 24), posterior cingulate (BA groups, providing additional evidence that the diver-
31), insula, brainstem, and cerebellum. The separate analy- gent change patterns reflect treatment-specific response
ses of the 2 change patterns were in fact necessary to de- effects.
termine which group drove these differences and in what
direction (Table). COMMENT
The dorsolateral prefrontal, inferior parietal, and hip-
pocampal differences identified in this conjunctional Reciprocal limbic increases (hippocampus, dorsal midcin-
analysis represented an inverse pattern for CBT and par- gulate) and cortical decreases (dorsolateral, ventrolat-
oxetine. The between-treatment differences in dorsal eral, and medial orbital frontal; inferior temporal and pa-
midcingulate, ventromedial frontal, and posterior cin- rietal) were identified following successful treatment with
gulate were related to unique changes with CBT treat- CBT. These regional changes involve sites similar, and
ment and were not seen with paroxetine at any statisti- in some cases identical, to those seen previously with par-
cal threshold (Table). Differences involving subgenual oxetine and other pharmacotherapies,21,37 but the changes
cingulate (BA 25), insula, brainstem, and cerebellum like- were in the opposite direction.